Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288705943> ?p ?o ?g. }
- W4288705943 endingPage "35399" @default.
- W4288705943 startingPage "35389" @default.
- W4288705943 abstract "Current guidelines recommend adjuvant chemotherapy (ACT) for stage II colorectal cancer (CRC) patients by using clinical high risk factors, with which circulating tumor cells (CTCs) were not considered. Here, an assessment to detect CTCs based on subtraction enrichment mediated by magnetic beads conjugated with CD45, immunofluorescence staining of CK, and fluorescence in situ hybridization of CEP8 is established. Both CEP8- and CK-positive CTCs have the potential to improve the risk stratification of stage II CRC patients. Patients with preoperative CTCs of ≥4 had a significantly higher recurrence risk than those with preoperative CTCs of <4 in two external validation cohorts (P < 0.0001). In the subgroup with clinical high risk, when preoperative CTCs were <4, patients did not benefit from ACT (P = 0.5764); however, when preoperative CTCs were ≥4, patients received benefit from ACT (P = 0.0064). Additionally, regardless of clinical risk status and preoperative CTC levels, if postoperative CTC levels were ≥4 for more than three consecutive time points (monitoring time interval, 2-6 months), the recurrence rate was 100%. Our findings suggested that the subtraction enrichment of CTCs could provide a reliable method to stratify the recurrence risk and make therapeutic decisions after surgery in stage II CRC patients." @default.
- W4288705943 created "2022-07-30" @default.
- W4288705943 creator A5002534200 @default.
- W4288705943 creator A5003861058 @default.
- W4288705943 creator A5020302124 @default.
- W4288705943 creator A5022624144 @default.
- W4288705943 creator A5024379236 @default.
- W4288705943 creator A5036146455 @default.
- W4288705943 creator A5038054864 @default.
- W4288705943 creator A5041680571 @default.
- W4288705943 creator A5044776577 @default.
- W4288705943 creator A5059433003 @default.
- W4288705943 creator A5065069403 @default.
- W4288705943 creator A5071037763 @default.
- W4288705943 creator A5080366436 @default.
- W4288705943 creator A5082372753 @default.
- W4288705943 date "2022-07-29" @default.
- W4288705943 modified "2023-10-18" @default.
- W4288705943 title "Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer" @default.
- W4288705943 cites W1571540962 @default.
- W4288705943 cites W1960485012 @default.
- W4288705943 cites W2017724350 @default.
- W4288705943 cites W2029864630 @default.
- W4288705943 cites W2040191699 @default.
- W4288705943 cites W2058935670 @default.
- W4288705943 cites W2103793201 @default.
- W4288705943 cites W2108816382 @default.
- W4288705943 cites W2111976640 @default.
- W4288705943 cites W2116483002 @default.
- W4288705943 cites W2118391054 @default.
- W4288705943 cites W2140970257 @default.
- W4288705943 cites W2141768150 @default.
- W4288705943 cites W2153930560 @default.
- W4288705943 cites W2156603564 @default.
- W4288705943 cites W2159352894 @default.
- W4288705943 cites W2167177168 @default.
- W4288705943 cites W2211065115 @default.
- W4288705943 cites W2282183033 @default.
- W4288705943 cites W2342231840 @default.
- W4288705943 cites W2344786963 @default.
- W4288705943 cites W2419065358 @default.
- W4288705943 cites W2460179076 @default.
- W4288705943 cites W2471944245 @default.
- W4288705943 cites W2482126832 @default.
- W4288705943 cites W2503541706 @default.
- W4288705943 cites W2554142345 @default.
- W4288705943 cites W2589824589 @default.
- W4288705943 cites W2606171824 @default.
- W4288705943 cites W2790919167 @default.
- W4288705943 cites W2791986466 @default.
- W4288705943 cites W2795929251 @default.
- W4288705943 cites W2800678179 @default.
- W4288705943 cites W2811502909 @default.
- W4288705943 cites W2903526531 @default.
- W4288705943 cites W2906385796 @default.
- W4288705943 cites W2931620373 @default.
- W4288705943 cites W2936067542 @default.
- W4288705943 cites W2952341590 @default.
- W4288705943 cites W2967681225 @default.
- W4288705943 cites W2969449618 @default.
- W4288705943 cites W2996752378 @default.
- W4288705943 cites W3000612336 @default.
- W4288705943 cites W3006569835 @default.
- W4288705943 cites W3012887203 @default.
- W4288705943 cites W3019378753 @default.
- W4288705943 cites W3027809255 @default.
- W4288705943 cites W3037786489 @default.
- W4288705943 cites W3083225270 @default.
- W4288705943 cites W3110971778 @default.
- W4288705943 cites W3134887329 @default.
- W4288705943 cites W3165501001 @default.
- W4288705943 cites W4211133582 @default.
- W4288705943 cites W4211168195 @default.
- W4288705943 cites W4214855086 @default.
- W4288705943 cites W4233588645 @default.
- W4288705943 doi "https://doi.org/10.1021/acsami.2c08560" @default.
- W4288705943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35904812" @default.
- W4288705943 hasPublicationYear "2022" @default.
- W4288705943 type Work @default.
- W4288705943 citedByCount "0" @default.
- W4288705943 crossrefType "journal-article" @default.
- W4288705943 hasAuthorship W4288705943A5002534200 @default.
- W4288705943 hasAuthorship W4288705943A5003861058 @default.
- W4288705943 hasAuthorship W4288705943A5020302124 @default.
- W4288705943 hasAuthorship W4288705943A5022624144 @default.
- W4288705943 hasAuthorship W4288705943A5024379236 @default.
- W4288705943 hasAuthorship W4288705943A5036146455 @default.
- W4288705943 hasAuthorship W4288705943A5038054864 @default.
- W4288705943 hasAuthorship W4288705943A5041680571 @default.
- W4288705943 hasAuthorship W4288705943A5044776577 @default.
- W4288705943 hasAuthorship W4288705943A5059433003 @default.
- W4288705943 hasAuthorship W4288705943A5065069403 @default.
- W4288705943 hasAuthorship W4288705943A5071037763 @default.
- W4288705943 hasAuthorship W4288705943A5080366436 @default.
- W4288705943 hasAuthorship W4288705943A5082372753 @default.
- W4288705943 hasConcept C121608353 @default.
- W4288705943 hasConcept C126322002 @default.
- W4288705943 hasConcept C143998085 @default.